Generic drug costs for US consumers to rise due to overdependence on China: CRS
APRIL 11, 2020 9:23:04 AM
The outbreak of COVID-19 in India could also affect the availability of generic pharmaceuticals in the United States. India, which supplies approximately 40 percent of generic pharmaceuticals used in the United States, imports nearly 70 percent of its APIs from China, CRS said.
.png)
No hay comentarios:
Publicar un comentario